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Ioanna Kyriakou8, Dimitris Emfietzoglou8, Michael L F Lerch1,2, Moeava Tehei1,2,
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Abstract
Gold nanoparticles have demonstrated significant radiosensitization of cancer treatment with
x-ray radiotherapy. To understand the mechanisms at the basis of nanoparticle radiosensitization,
Monte Carlo simulations are used to investigate the dose enhancement, given a certain
nanoparticle concentration and distribution in the biological medium. Earlier studies have
ordinarily used condensed history physics models to predict nanoscale dose enhancement with
nanoparticles. This study uses Geant4-DNA complemented with novel track structure physics
models to accurately describe electron interactions in gold and to calculate the dose surrounding
gold nanoparticle structures at nanoscale level. The computed dose in silico due to a clinical
kilovoltage beam and the presence of gold nanoparticles was related to in vitro brain cancer cell
survival using the local effect model. The comparison of the simulation results with radiobiological
experimental measurements shows that Geant4-DNA and local effect model can be used to predict
cell survival in silico in the case of x-ray kilovoltage beams.

1. Introduction
High atomic number (Z) nanoparticles (NPs), such as gold, platinum and ceramic metal oxide particles are
sub-cellular in size and are ideally suited to internalize within cells (Chithrani et al 2009, Jain et al 2012,
Engels et al 2017, 2018). When exposed to x-rays used in radiotherapy, NPs enhance local radiation doses
and increase cancerous cell destruction (Her et al 2017). This is due to an excess of low energy electrons
produced from the NPs, which deposit energy locally in the surrounding biological medium (Jain et al 2012).
With inert properties and high Z of 79, gold NPs (GNPs) are among the most researched candidates for
NP-enhanced cancer treatment using methods such as Monte Carlo simulations (Tran et al 2016, McKinnon
et al 2016, Zygmanski and Sajo 2016, Liu et al 2019), and both in vitro (Lin et al 2014, McDonald et al 2018)
and in vivo studies (Hainfeld et al 2008, 2013). The enhanced photoelectron production, emission of low
energy Auger electrons and fluorescence x-rays associated with the high-Z of gold cause significant localized
damage to cancer cells, particularly in kilovoltage (kV) radiation fields (Mesbahi 2010, Lin et al 2014).
Currently, kV radiotherapy is used to treat skin cancer (Kim and Kim 2017, 2018), but could be used to treat
brain and central nervous system cancers (CNS), (Joh et al 2013, Grotzer et al 2015, Engels et al 2016, 2020).
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Where normal tissue sparing remains a concern with standalone radiation treatments, GNPs offer a
means to better target cancerous cells, maintaining tumor control, while reducing the normal tissue
radiation dose (Mesbahi 2010). Optimal energies for dose enhancement effects with GNPs is estimated to be
60–90 keV using monochromatic beams due to the comparatively smaller x-ray absorption of tissues (or
water) at these energies (Boudou et al 2005).
1.1. Monte Carlo simulation and GNP-enhanced radiotherapy
Monte Carlo (MC) simulations describe particle transport in matter and interactions, and are widely
used to investigate the energy deposition around GNPs in the biological medium when irradiated by a
radiotherapeutic field. Simulations determine the effect of varying the size, distribution and shape of the
GNPs (Cho 2005, Jones et al 2010).
The physics models, included in the ‘general purpose’ MC codes such as EGS (Nelson et al 1985),
PENELOPE (Baró et al 1995), Geant4 (Agostinelli et al 2003), and MCNP (X-5 Monte Carlo Team 2005)
adopt a condensed history (CH) approach, where a large number of collision processes are grouped together
(‘condensed’), producing an artificial mean free path called a ‘step’. This approach has made MC simulations
a highly useful investigation tool, but inherently inadequate to describe detailed particle interactions at
nanometer scale and low energy (<keV).
Specialized MC codes, such as PTra (Grosswendt 2002) PARTRAC (Friedland et al 2011), KURBUC
(Nikjoo et al 2016), NOREC (Grosswendt 2002), and TRAX (Semenenko et al 2003) usually known as ‘track
structure codes’ (TS codes), have been developed to calculate the energy deposition at nanometer scale,
modelling particle tracks according to each physics process occurring, typically in gaseous medium or liquid
water, to approximate biological systems (Nikjoo et al 2016).
The Geant4 electromagnetic physics classes adopt the CH approach and contain models addressed to
medical physics applications (Arce et al 2020). One is based on the Livermore evaluated data library (Cirrone
et al 2010) with a recommended low-energy limit of 250 eV (Cullen et al 1991, 1997, Perkins et al 1991). The
second one is based on the Penelope MC code, valid down to approximately 100 eV (Fernandez-Varea et al
2012, Lazarakis et al 2018, Kyriakou et al 2019).
Geant4 is the only general-purpose radiation transport MC code which offers TS physics models to
describe particle interactions in liquid water at nanometer level, through the Geant4-DNA Package
(G4DNA), (Incerti et al 2010a, 2010b, Bernal et al 2015, 2018). This package currently provides a complete
set of models describing process by process the electromagnetic interactions of particles (including electrons,
protons, alpha particles and ions) with liquid water (Bernal et al 2015).
Sakata et al (2016) developed the first TS-based physics models within G4DNA capable of describing
electron interactions in GNPs (Sakata et al 2016, 2018). Such models have been refined in a second iteration,
where the Energy Loss Function formalism has been adopted to describe the ionization and excitation
processes in gold down to ∼10 eV (Sakata et al 2019). The new gold models adopt the ELSEPA code to
calculate elastic scattering cross-section (Sakata et al 2016).
1.2. Modelling cell survival
Translation from Monte Carlo simulations to in vitro experimental results is still sought after, particularly
concerning the nanoscale dose inhomogeneity produced by GNPs. The linear quadratic model (LQM) is
based on the linear quadratic nature of the cell survival curve, (Lechtman et al 2013, McMahon 2018). The
LQM relates the average dose, D, delivered to the cell population with x-rays, to the cell surviving fraction,
SX , according to equation (1)
( (
))
SX = exp − αD + βD2 .
(1)
The parameters α and β relate D to SX and can be evaluated experimentally in vitro. The LQM, in its
simplicity, is ideally suited to describe the effect of averaged and uniform radiation field doses on cell
survival. Due to this, the LQM is not well-suited to spatially fractionated or non-uniform dose fields such as
microbeam radiation therapy (Grotzer et al 2015) and particle therapy (Scholtz and Kraft 1994, Tran et al
2016). This has led to the development of other radiobiological models including the local effect model
(LEM), (Scholz and Kraft 1994, 1996, 2004).
The LEM, described in equations (2) and (3), is a more sophisticated approach to dose non-uniformity
than the LQM and was originally developed to determine the radiobiological effectiveness of heavy ion
radiation field for hadron therapy applications (Scholz and Kraft 1994). LEM relates energy depositions on
the nanoscale to the cell survival S, determined from in vitro experiments. S can be expressed as function of
the number of lethal events, N, following Poisson statistics, equivalent to equation (2)
S = exp (−N) .
2

(2)
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N is calculated by means of equation (3) where the local dose in the biological medium, D(x,y,z), due to the
incident x-ray field is used to compute a spatially dependent S(D(x,y,z)), obtained using equation (1), which
is evaluated at nanoscale volumes (dV) within a sensitive volume, VS
N = −∫

Vs

ln (S (D (x, y, z)))
dV.
Vs

(3)

The average number of lethal events due to a non-uniform radiation field, such as the one obtained with
NPs internalized in the cell (NNP ), can also be evaluated using this approach. Implementation of the LEM for
this purpose is described further in the method for our study.
Many correlations to in vitro studies with GNPs have been made using LEM (McMahon et al 2011,
Lechtman et al 2013, Ferrero et al 2017, McMahon 2018), however, this is the first study to investigate the
impact of new specialized G4DNA gold physics models (Sakata et al 2016, 2018) in GNP radio -enhancement
and how this is related to cell survival in vitro for a more realistic GNP distribution. This work calculates the
dose enhancement on the nanoscale with a single GNP and a simplistic model of the clustering GNPs around
the cell nucleus. G4DNA, with the novel specialized gold TS physics models was compared to the case with
the CH Livermore Package to describe particle interactions in the medium. The cell surviving fraction with
GNPs was then calculated in silico by applying the LEM to 9 l gliosarcoma cancer cells irradiated with kV
x-rays. Direct correlation was made between the computed cancer cell survival and the in vitro results with
GNPs.

2. Method
2.1. Cell experiment design
Cell experiments were carried out with 9 l gliosarcoma (9LGS), rat glioma cells derived from an
N-nitroso-N-methylurea (NMU)-induced tumor and were purchased from the European Collection of Cell
Cultures (ECACC). Cell cultures were maintained at 37 ◦ C and 5% (v/v) CO2 in a T75 cm2 tissue culture
flask containing complete-DMEM (Dulbecco’s Modified Eagle Medium, Gibco®, Life Sciences),
supplemented with 10% (v/v) FBS (Fetal Bovine Serum, Invitrogen) and 1% (v/v) PS
(penicillin/streptomycin, Gibco®, Life Sciences)).
GNPs with a diameter of 15 nm are studied in many radiosensitization studies (McQuaid et al 2016, Her
et al 2017). They are commonly used in vitro and in vivo experiments as they have low toxicity (Bobyk et al
2013), and show more lingering internalization and efficient localization at tumor site through the
vasculature supply (Domey et al 2015). AuroVistTM 15 nm diameter NPs are commercially available for
preclinical use (Nanoprobes Inc. NY). To prepare the GNPs, a portion of the original 200 mg ml−1 GNP
stock was diluted in phosphate buffered saline (PBS, Gibco®) to a final concentration of 10 mg ml−1 .
2.1.1. Cell imaging for simulation set up
Confocal imaging was performed to determine the distribution of GNPs in 9LGS, adapting a similar method
outlined by Kim et al (2015).
9LGS cells were incubated with or without GNPs in an ibidi® µ-slide, 8 well, chambered coverslip (ibidi
GmbH, Lochhamer Schlag 11, 82 166 Gräfelfing). GNPs were added to 9LGS cell medium 24 h before
imaging, at a final concentration of 500 µg ml−1 . Images were acquired with a Leica TCS SP5 confocal
microscope (Leica Microsystems Pty Ltd, Macquarie Park, 2113 Australia). After 24 h incubation, the µ-slide
was placed directly in the confocal microscope (without washing) on a movable stage and a 40x oil
immersion lens used to image cells once immersion oil was applied to the slide. An argon laser with
wavelength 488 nm was used to expose the cells and GNPs, in order to produce fluorescence or light scatter
from the sample. Light was detected using a photomultiplier tube in the range of 510–600 nm.
Bright field (BF) images were also collected. Images were obtained at multiple depths within the cell.
Figure 1 shows a confocal microscopic image of GNPs inside the 9LGS cells, with pixel size of 0.48 µm by
0.48 µm. The green light scatter indicates the presence of GNPs by exploiting the surface plasmon resonance
of gold above 10 nm (Kim et al 2015) and shows that the GNPs tend to congregate around the cell nucleus of
the 9LGS. This motivated the use of a simplistic geometrical model of the GNP configuration for the
evaluation of the LEM.
When using BF imaging alone (no laser, as shown in figure 1, top-left), there is no visible evidence of
GNPs. The accumulations of GNPs therefore are of a size much less than the BF visible resolution of
0.48 µm, and only appear present with laser light. These experimental findings have prompted the use of a
GNP upper size limit of 100 nm diameter in the simulation study to mimic the order of magnitude of the
largest possible GNP clusters, as well as the original single GNPs that are 15 nm diameter.
3
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Figure 1. Confocal microscopy of GNPs (shown in green) incubated in 9LGS for 24 h at a concentration of 500 µg ml−1 . Insert
(top-left), shows image of 9LGS cells without argon laser illumination. Dimensions of cell nuclei are shown.

In biological experiments multiple GNPs and GNP clusters often develop into larger structures which
affect the dose enhancement of the GNPs to the cell (McKinnon et al 2016, Liu et al 2019). For the LEM
method, the GNP-shell geometry resembling the realistic GNP distribution was therefore considered by
recording the positions of the GNPs over the entire volume of the 9LGS cell. On average, a shell-like
distribution was seen, as shown in figure 1, which was estimated in 3 dimensions to be 1 GNP thick
throughout the shell. It was also found that the GNPs were less likely to be on the top of the nucleus or on the
bottom against the flask. Therefore, a GNP shell distribution was modelled 2 µm from the top of the 9LGS
nucleus, 6 µm deep, and surrounding the 9LGS nucleus of 10 µm diameter (see figure 4).
2.1.2. Cell irradiation
24 hrs prior to irradiation, 500 µg ml−1 GNPs were added to 9LGS cells that were sub-cultured into
T12.5cm2 flasks (BD FalconTM ) containing c-DMEM. The irradiation of 9 l cells with and without GNPs was
performed at the Prince of Wales Hospital (Randwick, New South Wales, Australia 2031) using a Nucletron
Oldelft Therapax DXT 300 Series 3 Orthovoltage x-ray machine (Nucletron B.V., Veenendaal, The
Netherlands). T12.5cm2 flasks containing a monolayer of 9 l cells under 6 mm medium were positioned at a
distance of 50 cm from the x-ray tube. Flasks rested on a 10 cm solid water phantom and were surrounded by
6 mm of solid water to ensure full particle equilibrium. X-rays were generated at 150 kVp with a beam
current of 20 mA using inherent filtration of 3 mm beryllium with additional 0.35 mm of copper and
1.5 mm of aluminum (HVL = 0.68 mm Cu). Cells were irradiated with a dose rate of 0.754 Gy min−1 for
doses ranging from 1 to 8 Gy at 6 mm depth. Figure 2 shows the 150 kVp spectra.Following the x-ray
irradiation, cells were seeded at low density into 100 mm petri dishes containing 10 ml of c-DMEM. Each
independent flask was seeded in triplicate sets corresponding to each radiation dose including an
unirradiated control sets with and without GNPs to determine any toxicity due to GNPs. After 14 doubling
times (necessary to obtain an adequate number of colonies), each dish was washed with 5 ml PBS (calcium
and magnesium positive) and stained with a solution of 25% crystal violet solution (2.3% crystal violet, 0.1%
ammonium oxalate, 20% ethyl alcohol, from Sigma-Aldrich®, Australia) and 75% ethanol (v/v).
Surviving colonies of 50 cells or more were counted and divided by the original seeding number to
determine the plating efficiency (PE). For each treatment group, the PE was averaged, and standard deviation
of the mean calculated. The surviving fraction SX was evaluated by taking the ratio of the PE of the treated
cells and the PE of the non-irradiated control.
4
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Figure 2. 150 kVp orthovoltage x-ray spectra (generated using SpekCalc, Poludniowski et al 2009) used to irradiate 9LGS cells
experimentally and used in the simulation.

Figure 3. Geometry of the Monte Carlo simulation (sizes not to scale). The x-ray beam is incident normally on the water
phantom (A). The orange box shows the lateral dimensions of the incident beam. A single GNP is set at 6 mm depth in the
phantom. The G4DNA is active within VC (6 µm diameter sphere), with Livermore physics in the surrounding water volume, as
shown in the magnified view (B).

2.2. Simulation methods
2.2.1. Characterization of single GNP dose enhancement
To compare G4DNA TS physics models with the CH Livermore models, a single GNP was simulated
using Geant4 10.4 patch01 and placed at 6 mm depth in a liquid water phantom with dimensions of
12 × 12 × 12 mm3 to replicate the setup of the experimental study. A schematic of the simulation
geometry is shown in figure 3.
The incident radiation field modelled in the Geant4 simulation was the 150 kVp orthovoltage x-ray beam
used in the experiment (figure 2). A maximum of 1011 histories were simulated to obtain each set of results.
5
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The beam was incident normally to the water phantom with a lateral size of 10 µm. Two GNP radii were
considered; a GNP radius of 7.5 nm, corresponding to the real dimension of individual GNPs, and 50 nm, to
mimic a GNP aggregate, as observed with confocal imaging (figure 1). A cell volume (VC ) was added to
encompass the GNP with dimensions shown in figure 3(B).
The following situations were considered when modelling the physics processes in the simulation:
(a) G4DNA in the GNP (gold material) and VC (liquid water material). A cut of 10 eV was adopted. The
newly developed G4DNA models specialized for gold targets (described in Sakata et al 2018) were used
to model electron interactions in the GNP. The Livermore physics models were used to describe particle
interactions in the water phantom surrounding the VC , up to a distance of 6 mm, to reduce simulation
execution times.
(b) Livermore physics models were used throughout all the geometrical set-up (that is within the GNP,
within Vc and in the water phantom surrounding Vc).
Atomic de-excitation was also modelled. Auger electrons and fluorescence photons were simulated,
including the full relaxation cascade.
The Livermore physics models were adopted for the CH approach because Lazarakis et al (2018) and
Kyriakou et al (2019) showed that such models could begin to approximate G4DNA better than the other
available CH approaches of Geant4 when using a 10 eV secondary electron production lower energy limit,
while a limit of 250 eV has been recommended by the authors of the Livermore models (Guatelli et al 2007).
The low electron energy (LEE) limit controls the cut of the secondary electron production in the CH
models. The LEE limits of 10 eV and 250 eV were investigated in this study of the case of a 50 nm radius GNP
radioenhancement.
The simulation calculated the radial absorbed dose distribution from the surface of the GNP per incident
photon and the Dose Enhancement Ratio (DER). The DER is the ratio of the absorbed dose with and
without the GNP in water.
2.2.2. Dose enhancement of a GNP in a partial shell configuration
A GNP shell-like configuration was considered to match experimental observations (figure 1) and is similar
to the distribution previously described in McKinnon et al (2016) and Liu et al (2019). This design was
considered as there were some initial discrepancies with LEM using single GNPs (not shown) that we
estimated were due to incorrect extrapolation of realistic GNP geometry in 9LGS.
Vc, originally 3 µm in radius, was increased to 10 µm in radius to encompass the 9LGS cell nucleus which
has a radius of 5 µm, based on experimental observations (figure 1). The beam dimensions were increased to
24 × 24 µm2 accordingly.
In this geometrical cell configuration, the cell ‘nucleus’ with radius 5 µm, was partially surrounded with a
15 nm thick GNP shell. The confocal imaging showed that the GNPs were only visible using light scatter
from the 20 mW Argon laser, and have sizes smaller than the visible resolution. The GNP shells were
sometimes incomplete or had regions of thicker deposits of GNPs. On average, the coverage of the GNPs
around the nucleus of 9LGS was approximated to be 1 GNP thick (15 nm) with the top and bottom of the
nucleus uncovered by GNPs. This geometry in a simplistic sense mimics the average GNP distribution
surrounding the 9LGS nucleus using confocal imaging, and is shown in figure 4.
Figure 4 represents the geometrical set-up in Geant4, including dimensions of the GNP shell and
position of the incident beam. The inner radius of the GNP shell was set equal to 5 µm based on the 9LGS
nucleus size in the confocal images. The energy deposited within the cell nucleus was scored as well as 5 µm
outside the shell. G4DNA and Livermore physics models were activated for this simulation as described in
the next section.
2.3. Analysis using LEM-based radiobiological models
To determine the effect of the average dose enhancement due to the GNP shell congregation, a LEM
approach was considered which adapts equations (2) and (3). The dose D(x,y,z) is calculated in terms of
radial distance r, as D(r), and ranges from the origin at the center of VC to the interior surface of the GNP
shell in 1 nm steps (∆r = 1 nm), denoted by the total radius of VC (RC ).
Equation (3) can then be used to compute the lethal events due to the GNP alone (D(r)), after
subtracting the dose calculated without GNPs in water (D(r) = DGNP (r)—Dwater (r)). The lethal events due to
the GNP alone are shown in equation (4)
c (
)(
)
1 ∑
2
3
3
αD
(r)
+
βD(r)
(r
+
∆r)
−
r
.
R3C r=0

R

NNP =

6

(4)
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Figure 4. The partial GNP shell (yellow) modelled in the Geant4 simulation, shown from a beam view and 30◦ perspective. The
red arrow shows the direction of the incident beam. The 6 µm-wide GNP shell surrounds VC and begins at 2 µm depth from the
surface of VC , and was constructed to surround 60% of the cell as estimated from confocal imaging.

Characteristic parameters α and β were obtained from the experimental cell survival obtained in absence
of GNPs. For this study, the lethal events were considered to be inside the nucleus of 9LGS. Therefore D(r)
was calculated from the inside of the GNP shell.
The complete cell survival due to the GNPs (SNP ) and x-rays was then evaluated with the number of
lethal events created by x-ray interaction with the GNP alone (NNP ) and without the GNP (NX ), described in
equation (5)
SNP = exp(− (NNP + NX )) .

(5)

SNP was evaluated for each dose delivered to water (D in equation (1)), ranging from 1 to 10 Gy. The
additional dose predicted by LEM due to the GNPs in VC can also be recorded. The effective dose Deff
following treatment with 1 Gy of x-rays in the presence of GNPs was calculated by substituting S for SNP in
equation (1) and solving for D. This substitution is shown in equation (6)
− ln (SNP ) = αDeff + βD2eff .

(6)

Deff is the effective dose due to the GNPs and x-rays as calculated by the LEM, SNP is calculated using
equation (5), and the α and β parameters are due to x-ray irradiation of 9LGS only (no GNPs). The effective
dose was calculated using the quadratic formula. The effective dose enhancement DEeff in VC was then
derived as DEeff = Deff /1 Gy. For comparison, the average dose enhancement (DEav ) in VC was also
calculated.

3. Results
3.1. Experimental results
To characterize the effect of the AuroVistTM GNPs on 9LGS cells, a clonogenic assay was performed and
confirmed that the GNPs did not produce any intrinsic toxicity towards 9LGS cells, with a surviving
fraction of (1 ± 0.1). Figure 5 shows the clonogenic surviving fraction of 9LGS cells following
irradiation with 150 kVp orthovoltage x-rays with and without GNPs at a nominal concentration
of 500 µg ml−1 .
The addition of GNPs with increasing x-ray radiation dose, causes radiosensitization of the 9LGS cells, as
expected. As a result, the GNPs produce a reduction in the cell surviving fraction (shown by SNP ) across all
doses compared to x-rays alone (SX ). The 500 µg ml−1 concentration of GNPs and corresponding
enhancement is comparable to other radiosensitization studies with kilovoltage x-rays at similar
concentrations (McMahon et al (2011) and Lechtman et al (2013)). The α and β parameters, obtained by
fitting the SF curves with the LQM model, are shown in table 1.
7
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Figure 5. Clonogenic surviving fraction of 9LGS following 150 kVp orthovoltage x-ray irradiation, showing the surviving fraction
without GNPs, 0 µg ml−1 (SX ), and with 500 µg ml−1 GNPs (SNP ), and the corresponding linear quadtric model (LQM) fitted
lines. The continous and dashed black lines are the LQM fits to the radiobiological experimental data with without NPs (- NPs)
and with (+ NPs), respectively.

Table 1. Summary of the radiobiological parameters (α and β) due the radiation treatment of 9LGS cells with (500 µg ml−1 GNPs) and
without (0 µg ml−1 ) GNPs. LQM fits were performed in MATLAB® R2018b using the Curve Fitting ToolTM (MATLAB 2018). Errors are
within a 95% confidence interval.

α (Gy−1 )

Treatment
Control (0 µg ml−1 GNPs)
500 µg ml−1 GNPs

0.135 ± 0.052
0.334 ± 0.027

β (Gy−2 )
0.011 ± 0.008
0

The primary effect of the addition of GNPs to 9LGS was on the α parameter, which produces
significantly more linearity to the surviving fraction SNP and is often related to unrepairable double strand
DNA breaks (McMahon 2018).
These parameters will be used in the LEM in the final section.
3.2. Characterization of physics models for gold nanoparticles in Geant4
3.2.1. Radial dose calculation using different Geant4 physics models
GNP dose enhancement due exposure with an x-ray beam was investigated initially on single GNPs to
understand the differences between TS and CH physics models. The radial dose distribution and DER
produced around a single GNP of two sizes (7.5 or 50 nm) due to 150 kVp x-rays was compared in figure 6
using Livermore low energy limit cut (LEE) of 10 eV and G4DNA.
CH Livermore physics produced more dose near the GNP than the G4DNA TS models. With a low
energy limit of 10 eV (below the recommended 250 eV), the results obtained with Livermore show a DER of
(22.2 ± 3.9) and (47.5 ± 2.6) within 1 nm of the GNP for the 7.5 nm and 50 nm GNP radius, respectively.
G4DNA produced DERs of (18.7 ± 3.6) and (37.5 ± 1.9) at the GNP surface with 7.5 nm and 50 nm GNPs,
respectively, due to an overall greater electron stopping power in gold with the TS approach, as noted by
8

Phys. Med. Biol. 65 (2020) 225017

E Engels et al

Figure 6. Dose enhancement ratio (DER) with respect to the distance from the edge of the GNP, for 7.5 nm and 50 nm radius
GNPs, using the specialized TS gold physics models (G4DNA in the legend) and the Livermore models (Livermore in the legend).
Inserted graph shows the radial dose per incident photon using each physics model for a 50 nm radius GNP.

Sakata et al (2018). DER decreases with distance as low-energy secondary electrons originating in the GNP
deposit energy locally in the surrounding biological medium. Sakata et al (2018) likewise shows additional
absorbed dose produced with Livermore (but with LEE = 250 eV) compared to TS models up to 1 µm from
the center of a GNP with radius 30 nm.
The DER becomes equal to 1 at a radial distance of 250 nm using the 50 nm radius GNP for both TS and
Livermore models in our case. After this, the statistical fluctuation of DER lies within 3% of 1 (equivalent to
water) within 95% confidence level. However, some secondary electrons created by the GNP can travel to
micrometer distances away from the GNP, but these do not produce a significant change to the DER
produced by a single GNP.
3.2.2. Effect of Auger electrons on the radial dose distribution
The Auger electrons are suspected to be responsible for significant dose enhancement near GNPs (McMahon
et al 2011). Auger generation was switched off in the GNP region only and compared to complete Auger
activation throughout all volumes between Livermore (LEE = 10 eV) and G4DNA models in figure 7.
Our results confirm that Auger electrons have a significant impact on the energy deposited near the GNP,
as noted in previous studies (McMahon et al 2011). The additional dose produced by the Auger electrons
emitted by the 50 nm GNP is (43. ± 1.)% and (53. ± 2.) % when considering distances up to 500 nm from
the GNP surface, using the G4DNA and Livermore physics models (LEE = 10 eV), respectively.
3.2.3. Effect of the low electron energy limit cut
The kinetic energy of the secondary electrons leaving the GNP was scored for both the Livermore approach
and the G4DNA models to compare the effect of changing the Livermore LEE with G4DNA. Figure 8 shows
the kinetic energy spectra and number of electrons per incident photon emerging from a 50 nm radius GNP.
The spectra calculated with the two physics approaches are similar for energies above ∼1 keV. For lower
energies Livermore tends to produce more electrons, on average (1.4 ± 0.3) times for electrons below 5 keV,
which is expected due to the higher stopping power of the G4DNA models for gold and accurate modelling
of the production and transport of low energy electrons (Sakata et al 2018). Overall, G4DNA produces fewer
electrons from the GNP than Livermore.
The Livermore LEE = 250 eV spectra shows that there are no electrons with energy below 250 eV, as
expected. The LEE of 250 eV results in more energy deposition near the GNP due to the lost energy being
deposited locally rather than converted into δ-electrons.
9
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Figure 7. A comparison of the effect on the DER due to Auger electrons produced by the GNP using G4DNA (A) and Livermore
physics models (LEE = 10 eV) (B). For each physics model, Auger electron production in the GNP was switched off (white boxes)
and compared with the case with GNP Auger electrons switched on (black boxes).

Figure 8. Kinetic energy spectra of electrons leaving the GNP using G4DNA and Livermore physics models (LEE = 10 eV and
LEE = 250 eV). The main plot shows the kinetic energy of electrons per incident photon for G4DNA (red), Livermore
LEE = 10 eV (light blue) and LEE = 250 eV (dark blue). The inserted graph shows the ratio of the number of electrons emitted
when activating Livermore and G4DNA. Minimum bin size is 0.1 keV.

The average kinetic energy of electrons emerging from the GNP is (18 ± 1) keV, (21 ± 1) keV and
(24 ± 1) keV, when using the G4DNA and Livermore LEE = 10 eV and 250 eV, respectively. These energies
correspond to ranges between 7 µm to 9.5 µm in water, and 1 µm and 1.45 µm in gold (Berger et al 2000).
Therefore, the average electron will traverse a single GNP without self-absorption for both 7.5 nm and 50 nm
radius GNPs.
Figure 9 shows the effect of changing the Livermore LEE from 10 eV to 250 eV in terms of radial dose
distribution and DER, in the case of a GNP with a 50 nm diameter.
10 eV LEE provides a much better agreement with G4DNA than the 250 eV limit, confirming the results
of Lazarakis et al (2018) and Kyriakou et al (2019). When using LEE = 250 eV, Livermore produces larger
doses that diverges from G4DNA by 37% within 10 nm from the GNP surface. The LEE = 250 eV Livermore
produces a large dose deposition near the GNP due to the higher electron production cut leading to a higher
local energy deposition. These results show that the Livermore physics models, with a LEE of 10 eV, could be
10
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Figure 9. Radial dose distribution obtained with LEE equal to 10 eV and to 250 eV in the case of the Livermore physics. DER is
shown on main plot and radial dose per incident photon on inserted graph.

Figure 10. Dose per incident photon due to the GNP shell with Livermore LEE = 10 eV (blue) and LEE = 250 eV (black),
compared to G4DNA (red). The inserted image shows a 9LGS cell including the radius of the cell nucleus.

used when calculating the dose at sub-µm scale if TS codes are not available. This should be done with care,
given that the authors of the Livermore models recommend its use down to 250 eV.
Thus far, differences between G4DNA with TS-based code and CH Livermore have been identified for
GNP simulations involving radial dose on the nanoscale in a kV field. The next section will compare models
for more ‘realistic’ GNP geometry which will be used for the LEM comparison.
3.3. Partial shell GNP configuration and in silico cell survival
Rarely GNPs accumulate homogeneously within cells, instead GNPs aggregate into new configurations, such
as the ‘shell’-like structures in 9LGS (see figure 1). We simulated the shell to be 1 GNP (15 nm) thick based
on confocal imaging and constructed to surround 60% of the 9LGS nucleus volume with radius 5 µm, shown
in the insert on figure 10. The entire radial dose on the nanoscale was recorded inside VC , in figure 10, and
extending 1 µm beyond.
11
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Figure 11. ‘Realistic’ GNP distribution radial DER using G4DNA (red) and Livermore physics with a 10 eV (blue) and 250 eV
LEE (black). The DER near the GNP shell is zoomed in the top insert.

The dose per incident photon between Livermore and G4DNA is significantly different both in water and
when the GNP shell is present. Livermore produces (30 ± 4)% more dose than G4DNA in water alone. Using
the data presented in figures 10 and 11 shows the resulting radial DER for each physics model due to the
GNP shell, including an insert showing more detail within 200 nm of the GNP surface. In this case the
significant dose discrepancy between Livermore and G4DNA is eliminated by normalizing to water in the
DER calculation. However, there is still significant differences in the absorbed dose near the GNP.
The DER inside VC never approaches 1 in contrast to the case of a single GNP where DER = 1 from
∼70 nm from the edge of the NP. This occurs due to the greater number of high energy electrons that have
been produced from the greater likelihood of x-ray interaction with gold (the shell is made of thousands of
single GNPs). This highlights the benefit of the GNP-shell formation in largely increasing the dose to the
nucleus of cancer cells without having to be internalized into the nucleus, as mentioned in previous studies
as an ideal case to produce Auger electrons near DNA (McKinnon et al 2016, Engels et al 2017).
Comparing directly between CH Livermore with LEE = 10 eV and LEE = 250 eV and G4DNA for the
GNP shell, Livermore consistently produces greater radial dose and DER near the GNP surface, as noted in
the previous section. The Livermore (LEE = 10 eV) DER converges to the G4DNA DER after 800 nm from
the GNP surface, whereas the LEE = 250 eV never completely converges to G4DNA.
3.4. Evaluating LEM-based radiobiological models for clustered shell GNP configurations
The expected surviving fraction of 9LGS with GNPs (SNP ) using the LEM was calculated from the radial dose
profiles presented in figures 10 and 11, for CH Livermore (LEE = 10 eV and LEE = 250 eV) and G4DNA TS
codes. The resulting SNP for the models is shown in figure 12, compared to the experimental data for SNP and
SX (no GNPs).
Using the ‘realistic’ GNP distribution, the LEM method agrees with the experimental results. The large
changes in the DER gradient from the surface of the GNP shell are evaluated through calculation of the lethal
events at each 1 nm step from the shell using LEM.
This allows an effective dose due to the inhomogeneous dose field of the GNPs to be calculated inside VC .
Table 2 shows a comparison of the effective dose enhancement due to the GNP shell in VC using the LEM
(DEeff ) as calculated using equation (6), with the average dose enhancement in VC (DEav ) for each of the
physics models considered.
The DEeff is smaller than the average dose enhancement in VC for each physics approach considered. This
is due to the calculation of the cell survival with GNPs at each radial dose step from the GNP shell
minimizing the impact of the large dose near the GNP shell. In contrast, DEav is affected by this initial large
radial dose near the GNP surface (as seen in figure 11). This is a result of the assumption that there is no
interaction between GNP-related dose and water-only related dose (equation (5)), which reduces the impact
of the added dose from the NPs. As a result, the average dose enhancement provides over 2.2 times the dose
in water alone for each physics model and would cause a significant divergence in the predicted LQM cell
12
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Figure 12. Predicted cell surviving fraction using the LEM for the ‘realistic’ GNP shell distribution modelled with G4DNA (red
line), Livermore physics with LEE = 10 eV (blue line) and LEE = 250 eV (black line). The LEM-computed survival without GNPs
is shown for G4DNA. Experimental data with (SNP ) and without (SX ) GNPs, (white and black squares, respectively) is overlaid. In
the legends, ‘ + NP’ and “-NP) indicate with and without the NP in the biological medium.

Table 2. Effective dose enhancement in VC using LEM, compared to the average DER in VC , determined using G4DNA and Livermore
physics with LEE = 10 eV and 250 eV.

DEeff
DEav

G4DNA

Livermore LEE 10 eV

Livermore LEE 250 eV

1.72
2.28 ± 0.03

1.75
2.44 ± 0.04

1.89
2.22 ± 0.03

survival. For this study, the DEav was therefore not appropriate for GNP modelling of cell survival with our
GNP distribution.
Instead, the similar DEeff produced by G4DNA and 10 eV LEE Livermore produced a good agreement
with the experimental data. The higher effective dose enhancement using the 250 eV LEE Livermore model
increased the predicted cell killing of the SNP , as seen in figure 12.

4. Discussion
This study has characterized the variations in absorbed dose to water produced by single GNPs in an x-ray
field due to TS and CH physics models in Geant4. We applied these findings to simplistically model a GNP
distribution in Geant4 confocal imaging of GNPs in 9LGS cells, and calculate the corresponding cell survival
using the LEM. Our results show that the new TS-based G4DNA models for gold can produce a good
correlation to experimental GNP radiosensitization, if considering the nanoscale dose and a partial-shell
GNP structure.
Livermore CH models with an LEE of 10 eV provided a dose enhancement result that was more
consistent with the TS model than when using the recommended LEE of 250 eV.
Livermore physics produced 30% more dose in water than G4DNA. The greatest difference between
G4DNA and Livermore was the larger DER at the GNP surface regardless GNP size, and further increased
when increasing the cut threshold from 10 eV to 250 eV.
Livermore at LEE = 10 eV overall produced good agreement to G4DNA, in agreement with Lazarakis
et al (2018) and Kyriakou et al (2019). However, Livermore is not recommended to be used below 250 eV,
(Cullen et al 1991, 1997, Perkins et al 1991) with significant differences in terms of spectra of low energy
13
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secondary electrons and calculation of energy deposition around GNPs with respect to G4DNA (Sakata et al
2016, 2018).
When using TS and CH models, Auger electrons are predominantly contributing to single GNP dose
enhancement. For small radii, this happens when the GNPs are situated near or inside the cell nucleus to
maximize the DNA damage. With larger GNP distributions, where multiple GNPs interact to enhance the
dose to the cell, the higher energy electrons, and not the Auger electrons, enhance significantly the dose
distribution over micrometer distances (Coulter et al 2002, McKinnon et al 2016).
Previous studies have scarcely considered the effect of a more realistic GNP distribution in the LEM when
translating Monte Carlo results to radiobiological experiments. Instead, single GNPs are often used
(McMahon et al 2011, Ferrero et al 2017) with one study randomizing GNP positions within the cell before
applying the LEM using PENELOPE CH models (Lechtman et al 2013).
The distribution of GNPs must be considered carefully as it is known to differ between cell lines
(McMahon et al 2011, Brown and Currel 2017). More homogeneously distributed GNPs in cells can produce
good agreement between using a single GNP and the LEM, as the GNP systems are more isolated and
significant dose enhancements occur within 10–100 nm. However, in some cell lines (such as 9LGS), the
clustering of NPs causes superimposing and shielding effects on the dose enhancement (McKinnon et al
2016). Brown and Currel (2017) include components accounting for dose saturation when NP shells form
around 9LGS, and other cell lines in the LEM calculation. In our study, electrons with energies between
10–100 keV (figure 8) have a larger role in the dose enhancement in the cell when the GNPs are configured in
a ‘shell-like’ distribution. This was also noted by McKinnon et al (2016) and in other kV applications with
NPs (Engels et al 2016). Our GNP layer around 9LGS cells can be thicker than 1 GNP realistically (see
figure 1) and can be partially incomplete around the cell nucleus. This in turn affects the dose to the nucleus
and nearby cells, and may be of interest in future simulations.
Modelling multiple GNPs with accurate physics models and including real GNP distributions is an
important step to advance the modelling of NP radioenhancement by means of the LEM and Monte Carlo
simulations. Future studies should also consider the effect of indirect radiation damage by modelling
radiochemistry (Bernal et al 2015) and other radiobiological models besides LEM which incorporate DNA
damage on the nanoscale (Garty et al 2010).

5. Conclusion
This research marks the first use of the new Geant4 TS-based models for gold to predict GNP dose
enhancement in a cancerous cell line. This study has investigated simulation physics models (CH and TS)
and parameters (LEE) to describe GNP radioenhancement in kV beam when considering a distribution of
GNPs that more resembles the configuration of GNPs seen in an in vitro cell population.
We have demonstrated a noticeable difference in physics models in Geant4 on the nanoscale dose around
a gold nanoparticle. Overall, (CH) Livermore physics overestimated the dose and dose enhancement with
GNPs compared to Geant4-DNA models. The advantage of the TS-models in this study was an accurate
secondary electron production and tracking, which led to significant differences in terms of dose calculation
to the Livermore close to the GNP surface. Accurate low-energy electron tracking will become more
important for further studies investigating GNP radioenhancement considering realistic distributions of the
gold nanoparticles and when including the chemical stage modelling (radiolysis). When the TS models are
not available for modelling NP dose, using Livermore with a 10 eV LEE appears to be an alternative for NP
dose calculations. In addition, we underlined the necessity of simulating fully Auger emission, which directly
impacts DER.
The local effect model (LEM) was used to calculate the cancer cell survival according to an
approximation of a more realistic GNP distribution. A good agreement was found between the simulation
results and the experimental measurements. To our knowledge, this is the first study to use a shell-like
geometric model of GNPs in the translation of Monte Carlo to experimental data with the LEM. In future,
simulations should consider more realistic conditions, and we will be considering an alternative model which
instead calculates the direct and indirect (chemical) damage of radiation in a GNP configuration that is
based in individual particle positions in the cell.
This work contributes to the translation of Monte Carlo based studies in GNP dose enhancement to
experimental GNP radiosensitization. This study highlights the benefits of combining state of the art Monte
Carlo simulation with biological imaging, radiobiological models and in vitro studies.
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